REPLIGEN CORP Common Stock, Value, Issued
REPLIGEN CORP (RGEN) had Common Stock, Value, Issued of $564.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-07-29
- 2026-06-30: Common Stock, Value, Issued $564.00K.
- 2026-03-31: Common Stock, Value, Issued $564.00K.
- 2025-12-31: Common Stock, Value, Issued $563.00K.
- 2025-09-30: Common Stock, Value, Issued $563.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $564.00K 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $564.00K 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $563.00K 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $563.00K 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $563.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $562.00K 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $561.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $560.00K 10-Q · filed 2024-11-18 | |
| 2024-06-30 | $559.00K 10-Q/A · filed 2024-11-18 | |
| 2024-03-31 | $559.00K 10-Q/A · filed 2024-11-18 | |
| 2023-12-31 | $558.00K 10-K · filed 2025-03-14 | |
| 2023-09-30 | $558.00K 10-Q/A · filed 2024-11-18 | |
| 2023-06-30 | $557.00K 10-Q/A · filed 2024-11-18 | |
| 2023-03-31 | $556.00K 10-Q/A · filed 2024-11-18 | |
| 2022-12-31 | $556.00K 10-Q/A · filed 2024-11-18 | |
| 2022-09-30 | $555.00K 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $555.00K 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $554.00K 10-Q · filed 2022-04-27 | |
| 2021-12-31 | $553.00K 10-K · filed 2023-02-22 | |
| 2021-09-30 | $553.00K 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $550.00K 10-Q · filed 2021-07-27 | |
| 2021-03-31 | $549.00K 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $548.00K 10-K · filed 2022-02-17 | |
| 2020-09-30 | $526.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $525.00K 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $523.00K 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $521.00K 10-K · filed 2021-02-24 | |
| 2019-09-30 | $521.00K 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $481.00K 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $441.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $439.00K 10-K · filed 2020-02-26 | |
| 2018-09-30 | $439.00K 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $438.00K 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $437.00K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $436.00K 10-K · filed 2019-03-01 | |
| 2017-09-30 | $436.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $341.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $341.00K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $338.00K 10-K · filed 2018-02-22 | |
| 2016-09-30 | $338.00K 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $337.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $331.00K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $329.00K 10-K · filed 2017-02-23 | |
| 2015-09-30 | $329.00K 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $329.03K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $328.51K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $328.00K 10-K · filed 2016-02-25 | $327.74K 10-K · filed 2015-03-17 |
| 2014-09-30 | $327.03K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $326.59K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $320.41K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $319.26K 10-K · filed 2015-03-17 | |
| 2013-09-30 | $318.83K 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $318.14K 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $314.25K 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $311.95K 10-K · filed 2014-03-14 | |
| 2012-09-30 | $310.55K 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $308.46K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $308.36K 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $307.15K 10-K · filed 2013-03-15 | |
| 2011-09-30 | $307.15K 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $308.12K 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $308.12K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |